The Latest Breaking News on Pharma

The Competition and Markets Authority (CMA) is investigating the price of antibiotics after prices recently are said to have shot up

Pfizer Inc. cemented a deal first announced in March to sell its antiviral medication Paxlovid in China through a state-owned company, adding to supply of COVID treatments in the country that’s now facing a massive infection surge.

While the moderate inflation rate for November has boosted investor sentiment and may have paved the way for lower interest rate hikes from this month, Fed’s recent comments suggest that the target interest rate may be a bit further ahead. Hence shares of fundamentally strong businesses with robust demand, such…

The Oireachtas Justice Committee examined the possible legalisation of some drugs

With the Labor Department reporting slower inflation in November and optimism about a reduced magnitude of interest rate hikes, investors are anxiously awaiting a year-end rally. Therefore, fundamentally strong stocks Pfizer (PFE), Murphy USA (MUSA), and Berry Corporation (BRY) could be solid investments now. Keep reading….

Pharmacies have complained they are facing financial ruin amid claims that wholesalers have vastly inflated prices due to demand

World Health Organization chief Tedros Adhanom Ghebreyesus said on Wednesday he is "hopeful" that the COVID-19 pandemic will no longer be considered a global emergency some time next year.

Competition and Markets Authority gathering evidence after drug companies accused of inflating prices

Sir Pascal Soriot was speaking after he was knighted by the King at Windsor Castle on Wednesday.